v3.20.4
Consolidated Balance Sheets - USD ($)
$ in Thousands
Dec. 31, 2020
Dec. 31, 2019
Current assets:    
Cash and cash equivalents $ 72,211 $ 85,452
Accounts receivable, net 286,314 134,617
Inventory, net 132,341 53,434
Other current assets and prepaid expenses 32,313 50,542
Total current assets 523,179 324,045
Property, plant and equipment, net 140,554 127,111
Intangible assets, net 475,002 528,962
In-process research and development 590,200 590,200
Goodwill 680,602 671,940
Investments 15,731 20,746
Operating lease right-of-use assets 37,735 39,380
Other assets 10,060 6,888
Total assets 2,473,063 2,309,272
Current liabilities:    
Accounts payable 100,883 62,537
Accrued expenses 240,869 164,925
Current maturities of operating leases 9,028 12,038
Current portion of lines of credit and notes payable 24,703 9,619
Total current liabilities 375,483 249,119
Operating lease liabilities 29,760 27,665
Convertible notes 221,989 211,208
Deferred tax liabilities 137,208 118,717
Other long-term liabilities, principally contract liabilities, contingent consideration and lines of credit 37,072 87,804
Total long-term liabilities 426,029 445,394
Total liabilities 801,512 694,513
Equity:    
Common Stock - $0.01 par value, 1,000,000,000 shares authorized at December 31, 2020 and 2019, respectively; 670,585,576 and 670,378,701 shares issued at December 31, 2020 and 2019, respectively 6,706 6,704
Treasury Stock, - 549,907 shares at December 31, 2020 and 2019, respectively (1,791) (1,791)
Additional paid-in capital 3,152,694 3,142,993
Accumulated other comprehensive loss (4,225) (22,070)
Accumulated deficit (1,481,833) (1,511,077)
Total shareholders’ equity 1,671,551 1,614,759
Total liabilities and equity $ 2,473,063 $ 2,309,272

Source